Lipocine Inc.LPCNNASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +1514.99% | -98.77% | +595.42% | +0.00% |
| Gross Profit Growth | +0.00% | +1514.99% | -98.77% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | -164.21% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | -164.86% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | -153.08% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | -153.03% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | -153.03% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +2.19% | +0.97% | +0.62% | +0.15% | +1.22% |
| Weighted Average Shares Diluted Growth | +1.06% | +2.00% | -0.17% | +0.15% | +1.22% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | -181.80% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | -181.80% | +0.00% | +0.00% |
| Receivables Growth | -29.90% | +130.50% | +78.79% | +91.29% | +26.01% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -16.38% | -2.13% | -19.44% | -19.34% | -22.35% |
| Book Value per Share Growth | -16.79% | +2.09% | -20.34% | -19.36% | -26.92% |
| Debt Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| R&D Expense Growth | -44.93% | +0.00% | -62.34% | +0.00% | +70.81% |
| SG&A Expenses Growth | +0.26% | -23.05% | -28.76% | -40.93% | -26.54% |